Autologous stem cell transplantation is still a valid option in good- and intermediate-risk AML: a GITMO survey on 809 patients autografted in first complete remission

F. Saraceni; B. Bruno; R. M. Lemoli; G. Meloni; W. Arcese; M. Falda; F. Ciceri; E. P. Alessandrino; G. Specchia; R. Scimè; R. Raimondi; A. Bacigalupo; A. Bosi; F. Onida; A. Rambaldi; F. Bonifazi; A. Olivieri

doi:10.1038/bmt.2016.233

Autologous stem cell transplantation is still a valid option in good- and intermediate-risk AML: a GITMO survey on 809 patients autografted in first complete remission

F. Saraceni, B. Bruno, R. M. Lemoli, G. Meloni, W. Arcese, M. Falda, F. Ciceri, E. P. Alessandrino, G. Specchia, R. Scimè, R. Raimondi, A. Bacigalupo, A. Bosi, F. Onida, A. Rambaldi, F. Bonifazi, A. Olivieri

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	Bone Marrow Transplantation
DOIs	https://doi.org/10.1038/bmt.2016.233
Publication status	Accepted/In press - Sep 26 2016

ASJC Scopus subject areas

Hematology
Transplantation

Access to Document

10.1038/bmt.2016.233

Cite this

Saraceni, F., Bruno, B., Lemoli, R. M., Meloni, G., Arcese, W., Falda, M., Ciceri, F., Alessandrino, E. P., Specchia, G., Scimè, R., Raimondi, R., Bacigalupo, A., Bosi, A., Onida, F., Rambaldi, A., Bonifazi, F., & Olivieri, A. (Accepted/In press). Autologous stem cell transplantation is still a valid option in good- and intermediate-risk AML: a GITMO survey on 809 patients autografted in first complete remission. Bone Marrow Transplantation. https://doi.org/10.1038/bmt.2016.233

Autologous stem cell transplantation is still a valid option in good- and intermediate-risk AML : a GITMO survey on 809 patients autografted in first complete remission. / Saraceni, F.; Bruno, B.; Lemoli, R. M.; Meloni, G.; Arcese, W.; Falda, M.; Ciceri, F.; Alessandrino, E. P.; Specchia, G.; Scimè, R.; Raimondi, R.; Bacigalupo, A.; Bosi, A.; Onida, F.; Rambaldi, A.; Bonifazi, F.; Olivieri, A.

In: Bone Marrow Transplantation, 26.09.2016.

Research output: Contribution to journal › Article › peer-review

Saraceni, F, Bruno, B, Lemoli, RM, Meloni, G, Arcese, W, Falda, M, Ciceri, F, Alessandrino, EP, Specchia, G, Scimè, R, Raimondi, R, Bacigalupo, A, Bosi, A, Onida, F, Rambaldi, A, Bonifazi, F & Olivieri, A 2016, 'Autologous stem cell transplantation is still a valid option in good- and intermediate-risk AML: a GITMO survey on 809 patients autografted in first complete remission', Bone Marrow Transplantation. https://doi.org/10.1038/bmt.2016.233

Saraceni, F. ; Bruno, B. ; Lemoli, R. M. ; Meloni, G. ; Arcese, W. ; Falda, M. ; Ciceri, F. ; Alessandrino, E. P. ; Specchia, G. ; Scimè, R. ; Raimondi, R. ; Bacigalupo, A. ; Bosi, A. ; Onida, F. ; Rambaldi, A. ; Bonifazi, F. ; Olivieri, A. / Autologous stem cell transplantation is still a valid option in good- and intermediate-risk AML : a GITMO survey on 809 patients autografted in first complete remission. In: Bone Marrow Transplantation. 2016.

@article{278560f884b14b03b0daf4209e1d602a,

title = "Autologous stem cell transplantation is still a valid option in good- and intermediate-risk AML: a GITMO survey on 809 patients autografted in first complete remission",

author = "F. Saraceni and B. Bruno and Lemoli, {R. M.} and G. Meloni and W. Arcese and M. Falda and F. Ciceri and Alessandrino, {E. P.} and G. Specchia and R. Scim{\`e} and R. Raimondi and A. Bacigalupo and A. Bosi and F. Onida and A. Rambaldi and F. Bonifazi and A. Olivieri",

year = "2016",

month = sep,

day = "26",

doi = "10.1038/bmt.2016.233",

language = "English",

journal = "Bone Marrow Transplantation",

issn = "0268-3369",

publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Autologous stem cell transplantation is still a valid option in good- and intermediate-risk AML

T2 - a GITMO survey on 809 patients autografted in first complete remission

AU - Saraceni, F.

AU - Bruno, B.

AU - Lemoli, R. M.

AU - Meloni, G.

AU - Arcese, W.

AU - Falda, M.

AU - Ciceri, F.

AU - Alessandrino, E. P.

AU - Specchia, G.

AU - Scimè, R.

AU - Raimondi, R.

AU - Bacigalupo, A.

AU - Bosi, A.

AU - Onida, F.

AU - Rambaldi, A.

AU - Bonifazi, F.

AU - Olivieri, A.

PY - 2016/9/26

Y1 - 2016/9/26

UR - http://www.scopus.com/inward/record.url?scp=84988733129&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84988733129&partnerID=8YFLogxK

U2 - 10.1038/bmt.2016.233

DO - 10.1038/bmt.2016.233

M3 - Article

AN - SCOPUS:84988733129

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

SN - 0268-3369

ER -

Autologous stem cell transplantation is still a valid option in good- and intermediate-risk AML: a GITMO survey on 809 patients autografted in first complete remission

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this